28.4 C
Vientiane
Wednesday, September 3, 2025
spot_img

Cision PR Newswire

From 50,000 to 700,000 SKUs: Speed Parts Drives 20%+ Annual Growth with Maropost

SUNSHINE COAST, Australia, Sept. 3, 2025 /PRNewswire/ -- Speed Parts, one of Australia's top automotive parts retailers, has turbocharged its growth with Maropost, scaling from 50,000 to over 700,000 SKUs while sustaining 20%+ annual revenue growth since 2018. Founded in 2003, Speed Parts has transformed from a local...

Trillium Flow Technologies Successfully Completes Refinancing

STAMFORD, Conn., Jan. 13, 2025 /PRNewswire/ -- Trillium Flow Technologies ("Trillium"), a portfolio company of First Reserve, and a global designer, manufacturer, and aftermarket...

ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow

The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro, extending ZEISS' LVC market leadership with treatment for myopia, hyperopia, and mixed...

Neuromodulation Wristband ObeEnd Reduces Heart Rate and Perceived Exercise Exertion

VANCOUVER, BC, Jan. 13, 2025 /PRNewswire/ -- WAT Medical Enterprise collaborated with Concordia University and Mitacs Canada to conduct a study using ObeEnd, the...

Addentax Invests Equity Stake in Fresh Food Marketing Solution Provider, Well Information Technology Corporation

SHENZHEN, China, Jan. 13, 2025 /PRNewswire/ -- Addentax Group Corp. ("Addentax" or the "Company") (Nasdaq: ATXG), an integrated service provider focusing on garment manufacturing,...

WXT Surged 101% in 24 hours, And the Price Exceeded $0.339.Why Can WXT Go to the Moon?

SINGAPORE, Jan. 13, 2025 /PRNewswire/ -- Platform tokens have gained increased attention in this bull market, with notable examples from leading exchanges. Amid this...

CARsgen’s Allogeneic CD19/CD20 CAR-T Therapy Administers First Dose in an Investigator-Initiated Trial

SHANGHAI, Jan. 13, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment...